Managing Burping (Aerophagia) in Patients on Adaptive Servo-Ventilation
For patients experiencing burping on ASV, reduce the expiratory positive airway pressure (EPAP) to the lowest effective level, consider switching to auto-EPAP mode if available, and ensure proper mask fit to minimize air swallowing.
Understanding the Problem
Burping during ASV therapy is typically caused by aerophagia—the swallowing of air that occurs when positive airway pressure forces air into the esophagus and stomach rather than exclusively into the lungs. This is a common and bothersome side effect that can significantly impact therapy adherence and quality of life.
Immediate Troubleshooting Steps
1. Pressure Optimization
- Lower the EPAP setting to the minimum level that still controls obstructive events
- Current ASV algorithms allow for variable EPAP (unlike older fixed-EPAP devices), which can help minimize excessive pressure 1
- Start by reducing EPAP by 1-2 cmH₂O increments and reassess symptoms
- The goal is finding the lowest pressure that maintains airway patency without causing aerophagia
2. Switch to Auto-EPAP Mode
- If your ASV device has auto-adjusting EPAP capability, activate this feature
- Auto-EPAP adjusts pressure dynamically throughout the night, using higher pressures only when needed
- Real-world data shows auto-EPAP usage varies by patient phenotype and can reduce overall pressure exposure 1
3. Mask Interface Assessment
- Check for proper mask fit—leaks can cause mouth breathing and increased air swallowing
- Consider switching mask types (nasal pillows → nasal mask → full face mask, or vice versa)
- Ensure the mask is not overtightened, which paradoxically can worsen leaks and aerophagia
Device-Specific Considerations
Modern ASV devices differ in their algorithms:
- Servo-controlled volume devices (e.g., ResMed) adjust pressure support based on target minute ventilation
- Servo-controlled flow devices (e.g., Philips) respond to flow patterns
- These differences can affect delivered pressures and aerophagia risk 1
If burping persists despite optimization, discuss with your equipment provider whether switching ASV device types might help, as different algorithms may suit individual patients better.
Clinical Context from Guidelines
The 2025 AASM guidelines emphasize that treatment decisions should prioritize patient-reported outcomes and quality of life improvement rather than solely focusing on eliminating respiratory events 2. Burping that impairs quality of life or threatens adherence warrants aggressive troubleshooting, as ASV effectiveness depends on consistent nightly use.
Common Pitfalls to Avoid
- Don't ignore the complaint—aerophagia can lead to therapy abandonment
- Don't assume higher pressure is always better—excessive pressure increases aerophagia risk without additional therapeutic benefit
- Don't overlook simple solutions—sometimes just changing eating patterns (avoiding large meals close to bedtime) helps
- Don't delay follow-up—persistent aerophagia requires device download review and possible in-lab titration
When to Escalate
If burping persists despite these interventions:
- Schedule an in-laboratory ASV titration study to directly observe pressure requirements and aerophagia
- Review device download data for excessive pressures or inappropriate ventilation patterns
- Consider alternative therapies if ASV cannot be tolerated (bilevel PAP with backup rate, CPAP for treatment-emergent CSA, or other modalities per guidelines 2)
Monitoring for Hyperventilation
While addressing aerophagia, be aware that inappropriate ASV settings can cause hyperventilation, which carries its own risks 1. Device downloads should show minute ventilation within normal ranges (typically 6-10 L/min for most adults). If minute ventilation is consistently elevated (>12 L/min), pressure support may need reduction regardless of residual apnea events.
The key principle: ASV therapy must be tolerable to be effective. Optimizing pressures to minimize side effects while maintaining therapeutic benefit is essential for long-term adherence and improved outcomes 2, 3.